GnRH agonist administration in assisted reproductive program

Effect of single dose of GnRH-agonist on pregnancy outcome in frozen-thawed embryo transfer cycles

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015031021420N1

Enrollment

221

Registered

2015-04-12

Start date

2014-04-03

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility, unspecified

Interventions

Intervention 1: intervention group:a single dose of GnRH agonist( 0.1 mg triptorelin) was administered three days after transfer. Intervention 2: Control group do not receive triptoreline0.1mg.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: patients in frozen-thawed embryo transfer cycle who have freezed embryo due to previous OHSS or supernumerary freezed embryos age of 18 to 40years

Exclusion criteria

Exclusion criteria: patients below the age of 18 and over 40 years, , , endometriosis, oocyte recipients patients who had systemic or endocrine disorders such as diabetes mellitus and thyroid disorders submucous fibroids or intrauterine adhesions with or without history of previous surgery

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy. Timepoint: 28 days after transfer. Method of measurement: vaginal sonography.	—

Secondary

Measure	Time frame
Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: BHCG test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Robab Davar

Yazd Reserch and Clinical center for infertility

r_davar@yahoo.com+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026